137 related articles for article (PubMed ID: 7079254)
1. [Effect of norethisterone acetate on ovarian functional activity].
Fanchenko ND; Anashkina GA; Kuzovkova NA; Adamian LV; Strizhakov AN
Probl Endokrinol (Mosk); 1982; 28(2):38-42. PubMed ID: 7079254
[TBL] [Abstract][Full Text] [Related]
2. Return of ovulation and fertility in women using norethisterone oenanthate.
Fotherby K; Yong-En S; Howard G; Elder MG; Muggeridge J
Contraception; 1984 May; 29(5):447-55. PubMed ID: 6744861
[TBL] [Abstract][Full Text] [Related]
3. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
Andino N
Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
[TBL] [Abstract][Full Text] [Related]
4. The use of biodegradable norethisterone implants as a 6-month contraceptive system.
Rivera R; Gaitan JR; Ortega M; Flores C; Hernandez A
Fertil Steril; 1984 Aug; 42(2):228-32. PubMed ID: 6745456
[TBL] [Abstract][Full Text] [Related]
5. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of norethisterone in women with subcutaneous implants of norethisterone acetate.
Joshi JV; Naik VK; Joshi UM
Indian J Med Res; 1979 Oct; 70():625-31. PubMed ID: 541006
[TBL] [Abstract][Full Text] [Related]
7. [Effect of norethisterone microdoses on the functional state of the hypophyseal-ovarian system].
Manuilova IA; Fanchenko ND; Anashkina GA; Sokolova ZP; Trutko NS
Probl Endokrinol (Mosk); 1980; 26(4):18-22. PubMed ID: 6774327
[TBL] [Abstract][Full Text] [Related]
8. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of norethisterone, estradiol and progesterone after administration of norethisterone oenanthate at different sites: a cross-over study.
Virutamasen P; Dhanapas S; Leepipatpaiboon S
Asia Oceania J Obstet Gynaecol; 1987 Mar; 13(1):49-53. PubMed ID: 3593083
[No Abstract] [Full Text] [Related]
10. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and biological justifications for the use of Triella].
McGuire JL; Pasquale SA; Castaigne JP
Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
Gupta GN; Saxena BB; Landesman R; Ledger WJ
Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
[TBL] [Abstract][Full Text] [Related]
13. [Morphological and biochemical characteristics of the endometrium of women taking small doses of norethisterone].
Kondrikov NI; Trutko NS
Akush Ginekol (Mosk); 1980 Jan; (1):45-7. PubMed ID: 7377479
[TBL] [Abstract][Full Text] [Related]
14. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
15. [Preclinical research and development of norethisterone].
Mcguire JL; Hahn DW; Philipps A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
[TBL] [Abstract][Full Text] [Related]
16. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
17. Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
Yassin S; El-mahgoub S; Ammar R; Karim M
Ain Shams Med J; 1971 Jul; 22(4):497-501. PubMed ID: 12256861
[TBL] [Abstract][Full Text] [Related]
18. Influence of nor-ethisterone enanthate on the structure of ovary, particularly corpus luteum.
Aghari K
J Obstet Gynaecol India; 1970 Jun; 20(3):393-6. PubMed ID: 12275253
[TBL] [Abstract][Full Text] [Related]
19. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
[TBL] [Abstract][Full Text] [Related]
20. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.
Rible RD; Taylor D; Wilson ML; Stanczyk FZ; Mishell DR
Contraception; 2009 Mar; 79(3):182-8. PubMed ID: 19185670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
